GET THE APP

Healing Power of Radiation: Advances in Radiation Therapy
..

Journal of Bioengineering & Biomedical Science

ISSN: 2155-9538

Open Access

Commentary - (2023) Volume 13, Issue 4

Healing Power of Radiation: Advances in Radiation Therapy

Anne Reed*
*Correspondence: Anne Reed, Department of Biomedical Data Science, University of Geisel School of Medicine, Hanover, USA, Email:
Department of Biomedical Data Science, University of Geisel School of Medicine, Hanover, USA

Received: 02-Aug-2023, Manuscript No. jbbs-23-113255; Editor assigned: 04-Aug-2023, Pre QC No. P-113255; Reviewed: 18-Aug-2023, QC No. Q-113255; Revised: 23-Aug-2023, Manuscript No. R-113255; Published: 30-Aug-2023 , DOI: 10.37421/2155-9538.2023.13.369
Citation: Reed, Anne. “Healing Power of Radiation: Advances in Radiation Therapy.” J Bioengineer & Biomedical Sci 13 (2023): 369.
Copyright: © 2023 Reed A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Introduction

Cancer, often referred to as the "emperor of all maladies," has plagued humanity for centuries. The battle against this formidable foe has witnessed various fronts, one of the most significant being radiation therapy. Radiation therapy, a cornerstone in the treatment of cancer, has evolved dramatically over the years, demonstrating the remarkable healing power of radiation. This essay explores the historical context, principles, technological advancements, and the future prospects of radiation therapy. Through advancements in technology and research, it now offers new hope to patients facing this formidable disease. The ability to target tumors with unprecedented accuracy while minimizing damage to healthy tissues underscores its importance in modern oncology [1].

Description

Radiation therapy's history is deeply rooted in the discovery of X-rays and radioactivity. In the late 19th and early 20th centuries, scientists like Wilhelm Conrad Roentgen and Marie Curie laid the groundwork for this groundbreaking medical treatment. The first radiation therapy success stories were seen in the early 20th century, with radium and X-rays being employed to treat various cancers. However, these early treatments were often crude and lacked precision, leading to significant collateral damage to healthy tissues. The field of radiation therapy began to advance in the mid-20th century with the development of linear accelerators, which could produce high-energy X-rays, enabling deeper and more precise tumor targeting [2].

Radiation therapy operates on the principle of using ionizing radiation to damage the DNA of cancer cells, thereby preventing their growth and division. This process, called cell death, is harnessed to eradicate cancer cells while minimizing harm to surrounding healthy tissues. Several key principles guide the application of radiation therapy. Radiation therapy is typically administered in multiple small doses, or fractions, over several days or weeks. This approach allows healthy cells to repair themselves between treatments, reducing side effects. High-energy X-rays or particles are generated externally and directed at the tumor from various angles to maximize dose to the cancer cells while minimizing exposure to healthy tissues. Modern radiation therapy machines incorporate imaging technologies such as CT scans to verify the tumor's position before each treatment session. This ensures precise targeting. IMRT tailors the radiation dose to the shape of the tumor by adjusting the intensity of radiation beams. This technique minimizes damage to surrounding tissues [3,4].

Advancements in technology have been instrumental in shaping the evolution of radiation therapy. Stereotactic Radiosurgery (SRS) for extremely precise, high-dose radiation to be delivered to small tumors or lesions in a single or a few treatment sessions. This is particularly effective for brain and spinal tumors. Proton therapy utilizes charged particles (protons) instead of X-rays to target tumors. Protons deposit most of their energy at the tumor site, sparing surrounding tissues. It's especially beneficial for pediatric and deep-seated tumors. Image-Guided Radiation Therapy (IGRT) combines real-time imaging with radiation delivery, ensuring the tumor's position is precisely targeted even as it moves due to breathing or other bodily processes. Brachytherapy involves placing radioactive sources directly within or near the tumor. It's used for cancers of the prostate, cervix, and other organs, delivering a high dose to the tumor while minimizing exposure to adjacent tissues [5].

Conclusion

In conclusion, radiation therapy stands as a testament to the remarkable progress achieved in the field of cancer treatment. From its humble beginnings to the present day, it has evolved into a highly targeted and effective means of combatting cancer, offering new hope and improved outcomes for patients worldwide. With ongoing research and technological advancements, the future of radiation therapy appears even brighter, promising increased precision, reduced side effects, and enhanced therapeutic outcomes. As we continue to unravel the complexities of cancer, radiation therapy remains an invaluable tool in the fight against this devastating disease, offering healing and solace to countless individuals and their families.

Acknowledgement

None.

Conflict of Interest

None.

References

  1. Gandhi, Saumil J., Andy J. Minn, Robert H. Vonderheide and E. John Wherry et al. "Awakening the immune system with radiation: Optimal dose and fractionation." Cancer Lett 368 (2015): 185-190.
  2. Google Scholar, Crossref, Indexed at

  3. Popp, Ilinca, Anca Ligia Grosu, Gabriele Niedermann and Dan G. Duda. "Immune modulation by hypofractionated stereotactic radiation therapy: Therapeutic implications." Radiother Oncol 120 (2016): 185-194.
  4. Google Scholar, Crossref, Indexed at

  5. Gao, Jianjun, John F. Ward, Curtis A. Pettaway and Lewis Z. Shi, et al. "VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer." Nat Med 23 (2017): 551-555.
  6. Google Scholar, Crossref, Indexed at

  7. Simper, Melissa S., Joyce E. Rundhaug, Carol Mikulec and Rebecca Bowen, et al. "The tumor promoting activity of the EP4 receptor for prostaglandin E2 in murine skin." Mol Oncol 8 (2014): 1626-1639.
  8. Google Scholar, Crossref, Indexed at

  9. Gundem, Gunes, Peter Van Loo, Barbara Kremeyer and Ludmil B. Alexandrov, et al. "The evolutionary history of lethal metastatic prostate cancer." Nature 520 (2015): 353-357.
  10. Google Scholar, Crossref, Indexed at

Google Scholar citation report
Citations: 307

Journal of Bioengineering & Biomedical Science received 307 citations as per Google Scholar report

Journal of Bioengineering & Biomedical Science peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward